$0.32
(Market cap
$235 Mln
Revenue (TTM)
$127 Mln
P/E Ratio
--
P/B Ratio
0.9
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.2 %
-
ROCE
-- %
-
Industry P/E
43.99
-
EV/EBITDA
-7.7
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-1.1
-
Face value
--
-
Shares outstanding
41,396,609
5 Years Aggregate
CFO
$-223.21 Mln
EBITDA
$-231.58 Mln
Net Profit
$-10.26 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Rxsight Inc (RXST)
| -42.4 | -21.2 | -30.3 | -57.7 | -37.0 | -- | -- |
|
BSE Sensex*
| -11.2 | -4.2 | -10.2 | -8.7 | 7.0 | 8.4 | 11.3 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Rxsight Inc (RXST)
| -69.7 | -14.6 | 218.2 | 12.6 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Rxsight Inc (RXST)
|
6.0 | 235.1 | 127.5 | -46.6 | -24.1 | -17.2 | -- | 0.9 |
| 7.6 | 5,202.6 | 6,552.2 | -551.4 | -4.3 | -9.9 | -- | 1.0 | |
| 260.9 | 6,982.1 | 2,589.9 | 168.8 | 21.4 | 2.5 | 43.5 | 1.0 | |
| 42.8 | 6,527.4 | 3,458.5 | -11.6 | 2.6 | -0.5 | -- | 2.7 | |
| 142.2 | 8,534.9 | 551.4 | -189.3 | -15.6 | -26.3 | -- | 11.7 | |
| 93.1 | 6,038.3 | 1,546.2 | 279.0 | 15.0 | 23.9 | 22.1 | 5.0 | |
| 178.8 | 9,346.3 | 1,558.5 | 76.3 | 19.6 | 9.5 | 44.3 | 11.8 | |
| 326.5 | 12,785.9 | 1,454.3 | 171.1 | 11.1 | 12.1 | 74.7 | 8.6 | |
| 104.2 | 5,802.7 | 763.3 | 51.4 | 11.7 | 2.5 | 113 | 3.3 | |
| 30.3 | 12,676.7 | 6,178.4 | 626.5 | 13.0 | 11.9 | 20.8 | 2.4 |
Shareholding Pattern
View DetailsAbout Rxsight Inc (RXST)
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that... enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is headquartered in Aliso Viejo, California. Address: 100 Columbia, Aliso Viejo, CA, United States, 92656 Read more
-
President, CEO & Director
Dr. Ronald M. Kurtz M.D.
-
President, CEO & Director
Dr. Ronald M. Kurtz M.D.
-
Headquarters
Aliso Viejo, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Rxsight Inc (RXST)
What is the current share price of Rxsight Inc (RXST) Today?
The share price of Rxsight Inc (RXST) is $6.00 (NASDAQ) as of 18-May-2026 16:03 EDT. Rxsight Inc (RXST) has given a return of -36.97% in the last 3 years.
What is the current PB & PE ratio of Rxsight Inc (RXST)?
Since, TTM earnings of Rxsight Inc (RXST) is negative, P/E ratio is not available.
The P/B ratio of Rxsight Inc (RXST) is 0.91 times as on 18-May-2026, a 69 discount to its peers’ median range of 2.91 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-10.97
|
1.55
|
|
2024
|
-48.84
|
4.77
|
|
2023
|
-28.20
|
8.55
|
|
2022
|
-5.31
|
3.95
|
|
2021
|
-3.23
|
1.14
|
What is the 52 Week High and Low of Rxsight Inc (RXST)?
The 52-week high and low of Rxsight Inc (RXST) are Rs 16.74 and Rs 5.30 as of 19-May-2026.
What is the market cap of Rxsight Inc (RXST)?
Rxsight Inc (RXST) has a market capitalisation of $ 235 Mln as on 18-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Rxsight Inc (RXST)?
Before investing in Rxsight Inc (RXST), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.